In spite of Covid-19 lock-downs and sent-home employees, GN have held on to R&D efforts
Even though the coronavirus pandemic led to employees being sent home and sales diving in 2020, hearing aid firm GN Hearing has steadfastly preserved its allocated resources for the development of new hearing aids, and now that a new product portfolio is on the market, CEO Gitte Aabo is confident 2021 will be a strong year.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Specialists such as engineers have defied the rampaging Covid-19 pandemic to work at full speed in the labs of Danish hearing aid firm GN Hearing, which did not allow the nightmarish year of 2020 to affect its innovative aspirations to deliver new and better products.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
GN Hearing expects 2021 comeback after tough year
For subscribers
